<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315038</url>
  </required_header>
  <id_info>
    <org_study_id>201801931A</org_study_id>
    <nct_id>NCT04315038</nct_id>
  </id_info>
  <brief_title>Metabolomics Profiling Research of Human Cerebrospinal Fluid in Aging Process</brief_title>
  <official_title>Metabolomics Profiling and Biomarker Research of Human Cerebrospinal Fluid in Aging Process and Age-related Neurodegenerative Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perform quantitative metabolomics on human cerebrospinal fluid (CSF) samples and establish&#xD;
      the first human CSF Metabolome Database of aging process in Taiwan.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Metabolomics is new science based on metabolite profiles in biofluids and tissues, which&#xD;
      under bioinformatics approaches and analyses could help to characterize metabolomic status of&#xD;
      CSF in aging process. In this prospective study, the investigators plan to enroll 200 health&#xD;
      volunteers and 40 neurodegenerative diseases patients with received operation under spinal&#xD;
      anesthesia. Blood and CSF samples will be analyzed using hydrogen-1 nuclear magnetic&#xD;
      resonance (1H-NMR) and lipid chromatography-mass spectrometry (LC-MS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Exam metabolic profiles of CSF in aging process and age-related neurodegenerative diseases</measure>
    <time_frame>An average of 1 year</time_frame>
    <description>Metabolites analysis of CSF will be investigated by NMR, LC-MS. Peak lists of all NMR and LC/MS/MS spectra will be searched against the database through a web server for metabolomic data analysis and further establish the CSF Metabolome Database.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Aging</condition>
  <condition>Metabolites</condition>
  <condition>Neurodegenerative Diseases</condition>
  <arm_group>
    <arm_group_label>All patients</arm_group_label>
    <description>Spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spinal anesthesia</intervention_name>
    <description>Plan to enroll 200 health volunteers and 40 neurodegenerative diseases patients with received spinal anesthesia. Blood will be collected at time point of pre-anesthesia 10 minutes and CSF samples will be collected at time point during spinal anesthesia induction. Blood will be collected, drawn into EDTA-coated tube.</description>
    <arm_group_label>All patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      CSF samples will be stored in aliquots at -80 °C before analysis. The sample will be analyzed&#xD;
      using hydrogen-1 nuclear magnetic resonance (1H-NMR) and lipid chromatography-mass&#xD;
      spectrometry (LC-MS) in the Metabolomic Core Laboratory at Chang Gung Memorial Hospital or&#xD;
      Chang Gung University. Demographic data including age, gender, body weight, blood pressure&#xD;
      and past medical data will be investigated.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with received spinal anesthesia and had written informed consent&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Aging groups:&#xD;
&#xD;
          1. . Above 20 years.&#xD;
&#xD;
          2. . No history of central nerve system injury and neurologic illness&#xD;
&#xD;
          3. . ASA≦II&#xD;
&#xD;
          4. . Written informed consent from the patient&#xD;
&#xD;
        Aged-related neurodegenerative diseases group:&#xD;
&#xD;
          1. . Above 60 years of age&#xD;
&#xD;
          2. . Medical record proved the history of Parkinsonism or Alzheimer disease&#xD;
&#xD;
          3. . ASA≦III&#xD;
&#xD;
          4. . Written informed consent from the patient or guardian by statute.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. patient refuses to sign informed consent&#xD;
&#xD;
          2. patients with coagulopathy, systemic infective disease and severe liver and renal&#xD;
             function impairment&#xD;
&#xD;
          3. patients with spine or brain tumor and CNS disease&#xD;
&#xD;
          4. the presence of severe and/or uncontrolled and/or unstable medical disease within 12&#xD;
             months prior to study (e.g. acute pancreatitis, stroke, liver cirrhosis, congestive&#xD;
             heart failure, and systemic immune disorder etc&#xD;
&#xD;
          5. Concurrent participation or planning to participate in another interventional clinical&#xD;
             trial (Concurrent participation in an observational trial allowed)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>March 13, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2020</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aging</keyword>
  <keyword>cerebrospinal fluid</keyword>
  <keyword>metabolomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurodegenerative Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

